Merit Medical (MMSI) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
1.4B
Gross Profit
643.3M
47.43%
Operating Income
156.1M
11.51%
Net Income
120.4M
8.87%
EPS (Diluted)
$2.03
Balance Sheet Metrics
Total Assets
2.4B
Total Liabilities
1.0B
Shareholders Equity
1.4B
Debt to Equity
0.75
Cash Flow Metrics
Operating Cash Flow
214.5M
Free Cash Flow
182.8M
Revenue & Profitability Trend
Merit Medical Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 1.4B | 1.3B | 1.2B | 1.1B | 963.9M |
| Cost of Goods Sold | 713.2M | 673.5M | 631.9M | 589.4M | 562.7M |
| Gross Profit | 643.3M | 583.9M | 519.1M | 485.3M | 401.2M |
| Operating Expenses | 487.2M | 456.4M | 418.0M | 406.9M | 355.3M |
| Operating Income | 156.1M | 127.5M | 101.1M | 78.4M | 45.9M |
| Pre-tax Income | 150.0M | 112.1M | 82.6M | 53.9M | -13.2M |
| Income Tax | 29.6M | 17.7M | 8.1M | 5.5M | -3.4M |
| Net Income | 120.4M | 94.4M | 74.5M | 48.5M | -9.8M |
| EPS (Diluted) | $2.03 | $1.62 | $1.29 | $0.84 | -$0.18 |
Income Statement Trend
Merit Medical Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 923.8M | 1.1B | 529.1M | 482.2M | 429.7M |
| Non-Current Assets | 1.5B | 1.2B | 1.1B | 1.2B | 1.2B |
| Total Assets | 2.4B | 2.3B | 1.7B | 1.6B | 1.7B |
| Liabilities | |||||
| Current Liabilities | 216.4M | 203.6M | 220.6M | 236.3M | 185.0M |
| Non-Current Liabilities | 822.8M | 919.7M | 298.9M | 372.2M | 520.8M |
| Total Liabilities | 1.0B | 1.1B | 519.6M | 608.5M | 705.8M |
| Equity | |||||
| Total Shareholders Equity | 1.4B | 1.2B | 1.1B | 1.0B | 958.6M |
Balance Sheet Composition
Merit Medical Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 120.4M | 94.4M | 74.5M | 48.5M | -9.8M |
| Operating Cash Flow | 214.5M | 142.2M | 124.2M | 108.6M | 123.1M |
| Investing Activities | |||||
| Capital Expenditures | 5.0K | 201.0K | 65.0K | 1.0M | 42.0K |
| Investing Cash Flow | -330.6M | -138.6M | -9.2M | -6.4M | -9.4M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | -60.0M | 559.3M | -60.3M | -98.4M | -95.7M |
| Free Cash Flow | 182.8M | 108.4M | 66.1M | 116.5M | 116.0M |
Cash Flow Trend
Merit Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
46.74
Forward P/E
25.70
Price to Book
3.94
Price to Sales
4.06
PEG Ratio
25.70
Profitability Ratios
Profit Margin
8.81%
Operating Margin
11.84%
Return on Equity
9.16%
Return on Assets
4.32%
Financial Health
Current Ratio
4.87
Debt to Equity
57.24
Beta
0.66
Per Share Data
EPS (TTM)
$2.04
Book Value per Share
$24.18
Revenue per Share
$23.75
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| mmsi | 5.6B | 46.74 | 3.94 | 9.16% | 8.81% | 57.24 |
| Intuitive Surgical | 189.7B | 77.39 | 11.09 | 15.96% | 28.41% | 0.00 |
| Becton, Dickinson | 50.0B | 33.87 | 1.98 | 5.89% | 7.18% | 76.34 |
| Avantor | 9.2B | 13.05 | 1.52 | 12.52% | 10.70% | 67.34 |
| Repligen | 7.3B | 511.11 | 3.67 | -1.16% | -3.53% | 34.44 |
| Stevanato | 7.0B | 47.54 | 4.95 | 9.14% | 11.16% | 27.86 |
Financial data is updated regularly. All figures are in the company's reporting currency.